NCT03477149 - EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 30, 2018

Primary Completion Date

March 11, 2020

Study Completion Date

March 11, 2020

Conditions

VaricoceleEndoleakPortal Vein ThrombosisBleedingAngiomyolipoma

Interventions

DEVICE

Easyx

Embolization will be done with Easyx liquid agent.

Trial Locations (1)

AP-HP - Hopital Europeen Georges-Pompidou Paris, France, Paris